Introducing Our Newest Board Member
Isabel Schlaepfer, University of Colorado, Boulder
Isabel Schlaepfer was born in Madrid, Spain and attended the Universidad Complutense and the Universidad de Navarra in Pamplona, where she graduated with a degree in Biochemistry. She joined the University of Colorado AMC in 1992 in the Division of Endocrinology, Metabolism and Diabetes, where she worked as a PRA for over a decade on lipid metabolism and genetics. She obtained her PhD from the Department of Integrative Physiology in 2008 plus a certificate in Behavioral Genetics from IBG in Boulder. In 2012 she joined the Department of Pharmacology in Denver as a Research Instructor.
Dr. Schlaepfer’s long term goal is to use her genetics and molecular and lipid metabolism training and apply it to investigate the fuel pathways used by cancer cells to grow and survive current anti-cancer treatments. She is currently doing cancer research supported by a K01 award from NCI. The main aspect of her project is the investigation of lipid and glucose metabolism in prostate cancer cells. Specifically, she is interested in using clinically safe drugs from the cardiovascular/obesity field to image and elucidate prostate cancer metabolic weaknesses that can be exploited in the clinic for more effective combinatorial therapies.